Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma

BACKGROUND: There is no standard therapeutic procedure for the hepatocellular carcinoma (HCC) in patients with poor hepatic reserve function. With the approval of newly developed chemotherapeutic agent of miriplatin, we have firstly conducted the phase I study of CDDP powder (DDP-H) and miriplatin c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kamimura, Kenya, Suda, Takeshi, Tamura, Yasushi, Takamura, Masaaki, Yokoo, Takeshi, Igarashi, Masato, Kawai, Hirokazu, Yamagiwa, Satoshi, Nomoto, Minoru, Aoyagi, Yutaka
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3482551/
https://ncbi.nlm.nih.gov/pubmed/22994941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-230X-12-127
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados